Human Genome Epidemiology Literature Finder
|
Records 1 - 13 (of 13 Records) |
| Query Trace: Anemia and FLT3[original query] |
|---|
| A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia. Haematologica 2007 Jun 92 (6): 744-52. Bacher Ulrike, Haferlach Torsten, Kern Wolfgang, Haferlach Claudia, Schnittger Susan |
| Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias. BMC cancer 2010 10 (1): 401. Rocquain Julien, Carbuccia Nadine, Trouplin Virginie, Raynaud Stéphane, Murati Anne, Nezri Meyer, Tadrist Zoulika, Olschwang Sylviane, Vey Norbert, Birnbaum Daniel, Gelsi-Boyer Véronique, Mozziconacci Marie-Joel |
| Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes. Clinics (São Paulo, Brazil) 2011 66 (5): 793-9. Machado-Neto João Agostinho, Traina Fabiola, Lazarini Mariana, Campos Paula de Melo, Pagnano Katia Borgia Barbosa, Lorand-Metze Irene, Costa Fernando Ferreira, Saad Sara T Olal |
| Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients. Cancer chemotherapy and pharmacology 2013 Oct 72 (4): 825-35. Kim Hye Ryun, Park Hyung Soon, Kwon Woo Sun, Lee Ji Hyun, Tanigawara Yusuke, Lim Sun Min, Kim Hyo Song, Shin Sang Jun, Ahn Jung Bae, Rha Sun You |
| Prognostic score including gene mutations in chronic myelomonocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Jul 31 (19): 2428-36. Itzykson Raphaël, Kosmider Olivier, Renneville Aline, Gelsi-Boyer Véronique, Meggendorfer Manja, Morabito Margot, Berthon Céline, Adès Lionel, Fenaux Pierre, Beyne-Rauzy Odile, Vey Norbert, Braun Thorsten, Haferlach Torsten, Dreyfus François, Cross Nicholas C P, Preudhomme Claude, Bernard Olivier A, Fontenay Michaela, Vainchenker William, Schnittger Susanne, Birnbaum Daniel, Droin Nathalie, Solary Er |
| Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation. European journal of haematology 2015 Mar . Peng Jie, Zuo Zhuang, Fu Bin, Oki Yasuhiro, Tang Guilin, Goswami Maitrayee, Priyanka Priyanka, Muzzafar Tariq, Medeiros L Jeffrey, Luthra Rajyalakshmi, Wang Sa |
| Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature. Oncotarget 2018 Jun 9 (45): 27882-27894. Kuendgen Andrea, Müller-Thomas Catharina, Lauseker Michael, Haferlach Torsten, Urbaniak Petra, Schroeder Thomas, Brings Carolin, Wulfert Michael, Meggendorfer Manja, Hildebrandt Barbara, Betz Beate, Royer-Pokora Brigitte, Gattermann Norbert, Haas Rainer, Germing Ulrich, Götze Katharina |
| Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML. The New England journal of medicine 2019 10 381 (18): 1728-1740. Perl Alexander E, Martinelli Giovanni, Cortes Jorge E, Neubauer Andreas, Berman Ellin, Paolini Stefania, Montesinos Pau, Baer Maria R, Larson Richard A, Ustun Celalettin, Fabbiano Francesco, Erba Harry P, Di Stasi Antonio, Stuart Robert, Olin Rebecca, Kasner Margaret, Ciceri Fabio, Chou Wen-Chien, Podoltsev Nikolai, Recher Christian, Yokoyama Hisayuki, Hosono Naoko, Yoon Sung-Soo, Lee Je-Hwan, Pardee Timothy, Fathi Amir T, Liu Chaofeng, Hasabou Nahla, Liu Xuan, Bahceci Erkut, Levis Mark |
| Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation. Annals of hematology 2021 Sep . Zhao Peng, Ni Ming, Ma Dan, Fang Qin, Zhang Yan, Li Yanju, Huang Yi, Chen Ying, Chai Xiao, Zhan Yun, Li Yan, Kang Qian, Zhao Mei, Liu Min, Zhang Fengqi, Huang Shisi, Wen Shuangshuang, Deng Bo, Wang Jis |
| Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia. International journal of clinical oncology 2021 8 26 (11): 2131-2141. Hosono Naoko, Yokoyama Hisayuki, Aotsuka Nobuyuki, Ando Kiyoshi, Iida Hiroatsu, Ishikawa Takayuki, Usuki Kensuke, Onozawa Masahiro, Kizaki Masahiro, Kubo Kohmei, Kuroda Junya, Kobayashi Yukio, Shimizu Takayuki, Chiba Shigeru, Nara Miho, Hata Tomoko, Hidaka Michihiro, Fujiwara Shin-Ichiro, Maeda Yoshinobu, Morita Yasuyoshi, Kusano Mikiko, Lu Qiaoyang, Miyawaki Shuichi, Berrak Erhan, Hasabou Nahla, Naoe Tomo |
| [Mutational Spectrum and Prognosis Analysis of AML Patients Based on High-Throughput Sequencing]. Zhongguo shi yan xue ye xue za zhi 2021 Apr 29 (2): 353-362. Li Jian-Xiong, Liu Heng, Sheng Hong-Xia, Zhang B |
| Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia. Leukemia 2023 10 . Jan-Niklas Eckardt, Sebastian Stasik, Christoph Röllig, Andreas Petzold, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W Krause, Regina Herbst, Mathias Hänel, Maher Hanoun, Ulrich Kaiser, Martin Kaufmann, Zdenek Rácil, Jiri Mayer, Uta Oelschlägel, Wolfgang E Berdel, Gerhard Ehninger, Hubert Serve, Carsten Müller-Tidow, Uwe Platzbecker, Claudia D Baldus, Andreas Dahl, Johannes Schetelig, Martin Bornhäuser, Jan Moritz Middeke, Christian Thie |
| Phase 3 study of gilteritinib versus salvage chemotherapy in predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia. Leukemia 2024 9 . Jianxiang Wang, Bin Jiang, Jian Li, Ligen Liu, Xin Du, Hao Jiang, Jianda Hu, Menghe Yuan, Taishi Sakatani, Takeshi Kadokura, Masato Takeuchi, Masanori Kosako, Xiao Ma, Larisa Girshova, Jerome Tan, Sergey Bondarenko, Lily Wong Lee Lee, Archrob Khuhapinant, Elena Martynova, Nahla Hasab |
- Page last reviewed:Feb 1, 2024
- Content source: